Viracta Therapeutics, Inc.
VIRX
$0.022
$0.005533.33%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.55M | -9.83M | -9.14M | -13.77M | -12.60M |
| Total Depreciation and Amortization | 110.00K | 96.00K | 110.00K | 123.00K | 128.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.13M | 1.15M | 1.50M | 1.31M | 1.26M |
| Change in Net Operating Assets | 2.22M | -1.25M | -318.00K | 2.31M | 679.00K |
| Cash from Operations | -7.09M | -9.83M | -7.85M | -10.03M | -10.54M |
| Capital Expenditure | -- | -- | -- | 0.00 | 51.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.16M | 11.70M | 14.19M | 9.27M | 9.05M |
| Cash from Investing | 8.16M | 11.70M | 14.19M | 9.27M | 9.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.92M | -1.00K | -6.68M | -- | -- |
| Issuance of Common Stock | 0.00 | 44.00K | 80.00K | 218.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.92M | 43.00K | -6.60M | 218.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -854.00K | 1.92M | -255.00K | -539.00K | -1.44M |